The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index; 52 of the 120 sources its claims cite were checked for support.
Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review
Open accessAbstract
Extracellular matrix (ECM) bioscaffolds have demonstrated therapeutic potential across a variety of clinical and preclinical applications for tissue repair and regeneration. In parallel, these scaffolds and their components have shown the capacity to modulate the immune response. Unlike synthetic implants, which are often associated with chronic inflammation or fibrotic encapsulation, ECM bioscaffolds interact dynamically with host cells, promoting constructive tissue remodeling. This effect is largely attributed to the preservation of structural and biochemical cues—such as degradation products and matrix-bound nanovesicles (MBV). These cues influence immune cell behavior and support the transition from inflammation to resolution and functional tissue regeneration. However, the immunomodulatory properties of ECM bioscaffolds are dependent on the source tissue and, critically, on the methods used for decellularization. Inadequate removal of cellular components or the presence of residual chemicals can shift the host response towards a pro-inflammatory, non-constructive phenotype, ultimately compromising therapeutic outcomes. This review synthesizes current basic concepts on the innate immune response to ECM bioscaffolds, with particular attention to the inflammatory, proliferative, and remodeling phases following implantation. We explore how specific ECM features shape these responses and distinguish between pro-remodeling and pro-inflammatory outcomes. Additionally, we examine the impact of manufacturing practices and quality control on the preservation of ECM bioactivity. These insights challenge the conventional classification of ECM bioscaffolds as medical devices and support their recognition as biologically active materials with distinct immunoregulatory potential. A deeper understanding of these properties is critical for optimizing clinical applications and guiding the development of updated regulatory frameworks in regenerative medicine.
Overview
CoChat Summary
TL;DR
This review argues that extracellular matrix (ECM) bioscaffolds are biologically active materials whose immune effects depend heavily on tissue source and, especially, decellularization/processing quality. Properly processed ECM tends to support resolution and constructive remodeling, while residual DNA, detergents, endotoxin, and other remnants can shift responses toward inflammation and fibrosis.
Key findings
- ECM bioscaffolds can promote a pro-remodeling immune response by preserving structural/biochemical cues, including degradation products and matrix-bound nanovesicles (MBV), which influence macrophage behavior and support transition from inflammation to repair.
- In the review’s summary of biomaterial response, implanted materials trigger an initial inflammatory phase followed by proliferative and remodeling phases; ECM bioscaffolds are described as gradually degraded by proteolytic enzymes, enabling host cell infiltration and replacement by host ECM.
- The paper states that commonly used decellularization thresholds for residual DNA are <50 ng dsDNA per mg dry ECM and DNA fragments <200 bp, but also says the precise levels required to avoid immune activation are context dependent and that the safety threshold remains arbitrary.
- Residual processing contaminants are emphasized as major risks: detergents can be cytotoxic and hinder recellularization, and endotoxin/LPS is described as one of the most potent inducers of innate immune activation; the paper notes that some commercial and investigational ECM products exceed FDA endotoxin thresholds.
Methods
- Narrative comprehensive review of the literature on immune responses to ECM bioscaffolds, focusing on implantation-related inflammation, proliferative healing, remodeling, and clinical/manufacturing implications.
- Synthesizes prior studies and reviews on decellularized tissue-derived ECM and purified ECM-based scaffolds, including evidence on macrophage phenotypes, DAMPs, endotoxin, crosslinking, carbohydrates, and MBV.
- No new data were created or analyzed in this study.
Limitations
- The paper states that many mechanisms remain not completely understood, especially how ECM degradation products drive immune modulation and how systemic immune effects should be interpreted.
- It explicitly notes that very few studies address several important topics, including physical properties of ECM scaffolds and patient factors such as sex/age/blood type; this is a limitation stated in the paper.
- Evident from the text: this is a review, not an original experimental study, so its conclusions depend on the quality and heterogeneity of the cited literature (say which: evident from the text).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
33 Valid · 4 Not valid · 25 Not checked · 26 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“research indicates that this immune regulation is not only at the local level, but also systemic, as suggested in studies with decellularized tissues [57,58], or MBV [76,168,197]”
§ Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review > 5.2. Implications for Clinical Applications
What the sources say
- Not checked — no full text of the sourcecites [57] Allman, 2002, The Th2-Restricted Immune Response to Xenogeneic Small Intestinal Submucosa Does Not Influence Systemic Protective Immunity to Viral and Bacterial Pathogens, Tissue Eng. source
- Disputedcites [58] Wolf, 2019, A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy, Sci. Transl. Med. sourceExperimental — accuracy not yet measured
The Discussion says the experiments examined the acute local immune response and that further investigation is needed to determine whether biologic scaffold implantation has systemic effects. Although the Results report IL-4 expression in draining lymph-node T cells, the paper does not present systemic immune regulation as an established finding. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Supportedcites [76] Crum, 2022, Immunomodulatory matrix-bound nanovesicles mitigate acute and chronic pristane-induced rheumatoid arthritis, NPJ Regen. Med. source
The Discussion reports that both systemic and local MBV administration mitigated arthritis in rats. It also reports reduced synovial inflammation and a systemic shift toward an anti-inflammatory myeloid phenotype, supporting immune regulation beyond the local level. (LLM, conf=0.94)
- Supportedcites [168] Crum, 2023, Mitigation of influenza-mediated inflammation by immunomodulatory matrix-bound nanovesicles, Sci. Adv. source
The Results section, under “MBV up-regulates systemic populations,” explicitly reports both local and systemic effects of MBV administration on T-cell populations. It also reports increased memory-like T-cell populations in the spleen, supporting the cited MBV example. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [197] Crum, 2023, Biocompatibility and biodistribution of matrix-bound nanovesicles in vitro and in vivo, Acta Biomater. source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“As a result, uncrosslinked ECM scaffolds are a risky option in scenarios where a challenging mechanical load is required, such as tendon augmentation [68,[204][205][206] or ventral hernia repair [207,208], leading to bulging or mechanical failure [191].”
§ Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review > 5.2. Implications for Clinical Applications
What the sources say
- Not matchedcites [68,[204][205][206]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Disputedcites [207] Golla, 2014, Outcomes following placement of non–cross-linked porcine-derived acellular dermal matrix in complex ventral hernia repair, Int. Surg. sourceExperimental — accuracy not yet measured
The citation to this paper is attached to ventral hernia repair, not tendon augmentation or the later bulging/mechanical-failure clause. For that application, the Discussion and Conclusion report low complication and recurrence rates after repair reinforced with non–cross-linked PADM, contrary to presenting it as a risky option. The study observed three recurrences among 47 patients during a mean 31-month follow-up. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [208] Ibrahim, 2015, Properties of meshes used in hernia repair: A comprehensive review of synthetic and biologic meshes, J. Reconstr. Microsurg. source
- Not checked — no full text of the sourcecites [191] Crum, 2024, Advances, challenges, and future directions in the clinical translation of ECM biomaterials for regenerative medicine applications, Adv. Drug Deliv. Rev. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The immune response to an implanted biomaterial is initiated by the inflammation caused by surgery itself.”
§ Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review > 2. Overview of the Immune Response to Implanted Biomaterials
What the sources say
- Partly supportedcites [6] Capella-Monsonís, H., Kearns, S., Kelly, J., and Zeugolis, D.I. (2019). Battling adhesions: From understanding to prevention. BMC Biomed. Eng., 1. sourceExperimental — accuracy not yet measured
The ‘Inflammatory response and coagulation mechanism’ section says surgery can disrupt tissue, followed by immune-cell infiltration and inflammation. It describes post-surgical adhesion formation, however, not the initiation of an immune response specifically to an implanted biomaterial. (LLM, conf=0.84)
- Could not verifycites [7] Li, H., Shan, W., Zhao, X., and Sun, W. (2025). Neutrophils: Linking Inflammation to Thrombosis and Unlocking New Treatment Horizons. Int. J. Mol. Sci., 26. sourceExperimental — accuracy not yet measured
The Introduction describes inflammation and innate immune responses generally, while Section 5 discusses responses to injury and infection. Our copy does not address implanted biomaterials or say that surgery-induced inflammation initiates the immune response to an implant (searched for implanted biomaterial, surgery, and foreign-body response). (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Extracellular matrix (ECM) bioscaffolds have demonstrated therapeutic potential across a variety of clinical and preclinical applications for tissue repair and regeneration.”
§ Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review > Abstract
What the sources say
- Supportedcites [1] Cramer, 2020, Extracellular Matrix-Based Biomaterials and Their Influence Upon Cell Behavior, Ann. Biomed. Eng. source
The Introduction reports effective use of ECM materials to repair and reconstruct various tissues in both preclinical animal studies and human clinical studies. The Summary describes their potential to facilitate favorable remodeling across a wide range of clinical applications. The paper also notes that outcomes are not always favorable, which is consistent with the claim of therapeutic potential rather than universal success. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [2] Hussey, 2018, Extracellular matrix-based materials for regenerative medicine, Nat. Rev. Mater. source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“However, the immunomodulatory properties of ECM bioscaffolds are dependent on the source tissue and, critically, on the methods used for decellularization.”
§ Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review > Abstract
What the sources say
- Supportedcites [1] Cramer, 2020, Extracellular Matrix-Based Biomaterials and Their Influence Upon Cell Behavior, Ann. Biomed. Eng. source
The Summary states that tissue source and decellularization protocol affect the cellular response to ECM bioscaffolds. The Tissue Source section reports different macrophage activation states for ECM from different tissues, while Decellularization Efficiency links inadequate cell removal to an intense inflammatory response. Page numbers are not provided in our copy. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [99] Badylak, 2014, Decellularized allogeneic and xenogeneic tissue as a bioscaffold for regenerative medicine: Factors that influence the host response, Ann. Biomed. Eng. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
35 more claims · 14 with their cited sources checked
Create a free account to see all 88 claims and to verify the 9 references still open.
- It may state two separate claims as one. 45
- Probably not a substantial claim. 5
Citations
Cites
Foreign body reaction to biomaterials
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.004 · Cited by 5,138 · cited 4×
“Unlike synthetic materials, which often elicit chronic inflammation or fibrotic encapsulation [3,4], ECM bioscaffolds engage with host cells in a dynamic manner, facilitating constructive healing [5].”
InfluentialCollagen Structure and Stability
Shoulders, M. D., & Raines, R. T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.032207.120833 · Cited by 3,923 · cited 1×
“Collagen, particularly type I, is the most widely used component due to its abundance, low immunogenicity, and ability to support cell adhesion, proliferation, and differentiation via integrin signaling [108].”
Regulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629 · cited 1×
“In this phase, new ECM is rapidly produced to repair the damaged tissues, and is dominated by the deposition of fibronectin, collagen type III, and collagen type I [36,37].”
An overview of tissue and whole organ decellularization processes
Crapo, P. M., Gilbert, T. W., & Badylak, S. F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.057 · Cited by 3,591
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015 · cited 4×
“Nonetheless, degradable materials can still elicit a pro-inflammatory response given other factors like cytotoxic byproducts of degradation [59,60], presence of processing chemicals [61], and pathogen contamination [10,62].”
InfluentialBendall, S. C., Simonds, E. F., Qiu, P., Amir, E.-A. D., Krutzik, P. O., Finck, R., Bruggner, R. V., Melamed, R., Trejo, A., Ornatsky, O. I., et al. (2011) · Science · doi:10.1126/science.1198704 · Cited by 2,279 · cited 1×
“CyTOF enables simultaneous measurement of more than 30 parameters per cell [49], and single-cell RNA-seq (scRNA-seq) profiles thousands of transcripts per cell, providing an unbiased view of macrophage states [50].”
Pankov, R., & Yamada, K. M. (2002) · Journal of Cell Science · doi:10.1242/jcs.00059 · Cited by 1,953 · cited 1×
“Fi-bronectin Fi-bronectin, another key ECM protein, facilitates early matrix organization, cell migration, and integrin-mediated signaling essential for tissue repair [110,111].”
FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data
Van Gassen, S., Callebaut, B., Van Helden, M. J., Lambrecht, B. N., Demeester, P., Dhaene, T., & Saeys, Y. (2015) · Cytometry Part A · doi:10.1002/cyto.a.22625 · Cited by 1,919 · cited 1×
“Coupled with modern dimensionality-reduction and clustering algorithms (e.g., t-SNE [51], FlowSOM [52]), these platforms resolve continuous phenotypic gradients and novel subpopulations [41].”
Extracellular matrix as a biological scaffold material: Structure and function
BADYLAK, S., FREYTES, D., & GILBERT, T. (2009) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.09.013 · Cited by 1,671 · cited 1×
“Although thresholds of 50 ng dsDNA per mg dry ECM and DNA fragments 200 bp are widely used, the precise levels required to avoid immune activation remain context dependent [128,129].”
Barczyk, M., Carracedo, S., & Gullberg, D. (2010) · Cell and Tissue Research · doi:10.1007/s00441-009-0834-6 · Cited by 1,512 · cited 1×
“After the inflammatory response onset, innate immune cells interact with the implanted material through transmembrane receptors called integrins [15] that activate metabolic pathways in response to mechanical [16,17] and biochemical stimuli [18].”
Research works printed but not linked: 3
- Hinton, 2008, Viualizing data using t-SNE, J. Mach. Learn. Res., 9, 2579
- Badylak, S.F. (2015). Host Response to Biomaterials: The Impact of Host Response on Biomaterial Selection, Academic Press.
- Lim, 2009, Effect of dispase denudation on amniotic membrane, Mol. Vis., 15, 1962
Cited by
Gaudio, L. D., Lattanzio, S., Pietro, R. D., & Sancilio, S. (2026) · Biomimetics · doi:10.3390/biomimetics11050330 · Cited by 4
“ECM scaffolds also contain matrix-bound nanovesicles (MBVs), which deliver bioactive lipids, proteins, and microRNAs (miRNAs), thereby modulating immune responses and supporting stem/progenitor cell recruitment [52].”
Surface modification of 3D-printed polycaprolactone (PCL) scaffolds for bone tissue engineering
Dehghani, S. A., Razavi, A., & Sahbafar, H. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103545 · Cited by 1
Stocco, E., Barbon, S., Cardaci, A., Barbazza, A., Confalonieri, M., Contran, M., Manzo, V., Todros, S., Pavan, P. G., Caro, R. D., et al. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1724094 · Cited by 2
“Although ECM preservation is not a direct marker of immunogenicity, it is critical for ensuring graft biocompatibility and promoting constructive host remodeling (Romero et al., 2025).”
Zhao, D., Ding, Y., Yan, Z., Zhao, J., Yu, M., Mou, X., & Cai, Y. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.115737
Moffa, A., Nardelli, D., Iafrati, F., Iannella, G., Pace, A., Baptista, P. M., & Casale, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062113
“The gel is allowed to self-assemble and adhere for approximately 30 s before excess is suctioned [23,24].”
Influential
Metadata
- Authors
- Romero, D. J., Hussey, G., & Capella-Monsonís, H.
- Affiliations
- University of Pittsburgh (US)
- McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA
- Venue
- Biologics
- Publisher
- MDPI AG
- Published
- 2025-09-05
- Volume
- 5
- Issue
- 3
- Pages
- 28
- ISSN
- 2673-8449 (ISSN-L)
- OpenAlex
- W4414022283
- Cited by
- 7
- References
- 206
- Citations by year
- 2026: 7
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biologics (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
- Keywords
- immune response, decellularization, innate immunity, inflammation resolution, tissue remodeling, tissue regeneration, scaffold bioactivity, bioactive materials
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review. https://app.cochat.ai/papers/10.3390/biologics5030028
- The paper
- Romero, D. J., Hussey, G., & Capella-Monsonís, H. (2025). Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review. Biologics. https://doi.org/10.3390/biologics5030028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.